Trial Profile

A Study Examining the Pharmacodynamics Interaction Between Buprenorphine and Fentanyl

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 18 Apr 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Buprenorphine (Primary) ; Fentanyl; Ondansetron
Indications Opioid-related disorders
Focus Pharmacokinetics
Sponsors Indivior

Most Recent Events

08 Apr 2022 According to an Indivior media release, data from this study will appear in an upcoming print issue of JCI Insight, a peer-reviewed journal
27 Jan 2022 According to an Indivior media release, results from this trial will appear in an upcoming print issue of PLOS ONE.
27 Jan 2022 Results published in an Indivior Media Release.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com